| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f59653069a5d23cf93c3477153fc0e2f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-435 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-163 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
| filingDate |
2018-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b23319098e78237ddc0e05c9c9f9a67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0428c937cbfa6f3a100c22e086b70753
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e74f67b243284fc8dc9ab2275eb44ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bedb6de8420ea698f9515fbd6a2e2f3 |
| publicationDate |
2019-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101983216-B1 |
| titleOfInvention |
Antibodies for determining an activity of botulinum toxin and a method for using the same |
| abstract |
The present invention relates to an antibody for the assay of botulinum toxin activity, and to an antibody composition comprising said antibody. Currently, the need for the development of a cell-based potency assay (CBPA) to replace the mouse LD 50 bioassay (MLD 50 ) is required in the field of botulinum toxin potency measurement. The antibody for the botulinum toxin activity assay of the present invention is an antibody for CPBA for replacing MLD 50 , and is a monoclonal antibody having remarkably high binding affinity and specificity for SNAP25. In addition, the antibody of the present invention overcomes the limitations of the conventional CPBA and enables development of more effective CBPA, and thus it is expected to be actively used in the pharmaceutical and cosmetic fields. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210045569-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11360081-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102274841-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021075834-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020111449-A1 |
| priorityDate |
2018-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |